首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:International journal of risk & safety in medicine

缩写:

ISSN:0924-6479

e-ISSN:1878-6847

IF/分区:0.9/N/A

文章目录 更多期刊信息

共收录本刊相关文章索引495
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Davoud Ahmadimoghaddam,Paniz Akbari,Maryam Mehrpooya et al. Davoud Ahmadimoghaddam et al.
Background: Most research on the impact of medication reconciliation on patient safety focused on the retroactive model, with limited attention given to the proactive model. ...
Bungaran Panggabean,Budi Suharjo,Ujang Sumarwan et al. Bungaran Panggabean et al.
Background: The global COVID-19 pandemic has forced people to obtain health products and services from home. Similar to other e-commerce, medicines are bought online and delivered using a courier service. ...
Chelsea Wilgenbusch,Crombie Stebner,Rhonda Bryce et al. Chelsea Wilgenbusch et al.
Background: Physicians encounter stressors with potential long-term psychological consequences. However, a comprehensive picture of post-traumatic stress disorder (PTSD) prevalence and symptomatic work-related event occur...
João Joaquim,Cristiano Matos,Ramona Mateos-Campos João Joaquim
Background: Since the mid-20th century, contrast agents have been widely used in radiology due to their ability to provide high-definition radiographic images and greater precision in diagnostic exams. Different types of ...
Ivan V Sychev,Natalia P Denisenko,Anastasiya A Kachanova et al. Ivan V Sychev et al.
Background: Angioneurotic edema is the most dangerous complication in angiotensin-converting enzyme inhibitors (ACEIs) therapy. Based on the current data, the clinical and genetic predictors of angioedema development are ...
Jeffrey R Vittengl,Robin B Jarrett,Eunyoe Ro et al. Jeffrey R Vittengl et al.
Background: Although antidepressant medication (ADM) has produced small advantages over pill placebo in randomized controlled trials, consuming ADM has predicted prospectively increasing depressive symptom severity in sam...
Peter C Gøtzsche,Maryanne Demasi Peter C Gøtzsche
Background: Depression drugs can be difficult to come off due to withdrawal symptoms. Gradual tapering with tapering support is needed to help patients withdraw safely. ...